Research and Development

Please view our Safe Harbor Statement

Capstone Therapeutics is a biotechnology company committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with under-served conditions. The Company is focused on the development and commercialization of AZX100 and Apo E mimetic peptide AEM-28 and analogs (through its investment in LipimetiX Development LLC).


  View Mode of Action



AZX100 in Human Fibroblast Video

  Example of cellular biologic effect of AZX100 in a laboratory experiment utilizing an in-vitro commercial fibroblast cell line.

Click here to see video